GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (FRA:2M7C) » Definitions » Forward PE Ratio

China Medical System Holdings (FRA:2M7C) Forward PE Ratio : 0.00 (As of May. 24, 2024)


View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings Forward PE Ratio?

China Medical System Holdings's Forward PE Ratio for today is 0.00.

China Medical System Holdings's PE Ratio without NRI for today is 6.62.

China Medical System Holdings's PE Ratio for today is 6.62.


China Medical System Holdings Forward PE Ratio Historical Data

The historical data trend for China Medical System Holdings's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings Forward PE Ratio Chart

China Medical System Holdings Annual Data
Trend 2018-12 2019-12 2020-12 2021-12 2022-12 2023-12 2024-01
Forward PE Ratio
6.85 10.20 6.22 8.39 7.44 8.36 7.84

China Medical System Holdings Semi-Annual Data
2018-03 2018-06 2018-09 2018-12 2019-03 2019-06 2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12
Forward PE Ratio 17.24 15.48 10.36 6.85 7.01 6.79 8.10 10.20 7.61 8.33 6.81 6.22 11.09 15.08 9.36 8.39 8.46 8.26 5.88 7.44 7.92 8.49 7.31 8.36

Competitive Comparison of China Medical System Holdings's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical System Holdings's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where China Medical System Holdings's Forward PE Ratio falls into.



China Medical System Holdings Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


China Medical System Holdings  (FRA:2M7C) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


China Medical System Holdings Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical System Holdings (FRA:2M7C) Business Description

Traded in Other Exchanges
Address
510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.

China Medical System Holdings (FRA:2M7C) Headlines

No Headlines